Polygenic Risk Scores in Chronic Hepatitis B–Related HCC: Promise Beyond Conventional Models?

Key Points

• Evaluate the potential of polygenic risk scores as predictors for hepatocellular carcinoma (HCC) in chronic hepatitis B cases.
• Literature review of current models on HCC prediction.
• Discussion on the integration of polygenic risk scores.
• Comparison of polygenic scores with traditional assessment methods.
• Polygenic risk scores may enhance predictive accuracy for HCC outcomes.
• Conventional models may benefit from the addition of genetic data.
• The analysis highlights the need for further research in genetic biomarkers.